TIM HOFFMANN
CFO, GLOBAL INITIATIVES
ÖSSUR/EMBLA MEDICAL
WHY: Recognized as a rising star at the Business Journal’s 17th annual CFO of the Year Awards in 2024. Has played a key role in Embla Medical’s strong financial performance and global expansion. The Icelandic medical device company with U.S. offices in Irvine saw growth in profitability since he joined the company. From 2021 to 2024, the company reported about $800M in revenue annually.
IN THE NEWS: Former CFO for the Americas promoted to CFO of global initiatives for parent company Össur. Oversaw 6% sales growth in 2024, led by prosthetics and neuro orthotics. Plans to expand access to patients in Asia and Africa.
NOTABLE: Former championship-winning volleyball player at UCLA.
QUOTABLE: “We’ve consistently delivered strong results on the top line and are trying to draw profitable growth.”
